Islet cell transplantation: The future?

Langenbeck's Archives of Surgery

Volumn 385, Issue 6, 2000, Pages 373-378

  Berney, Thierry ^a   Ricordi, Camillo ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes mellitus; Islet cell transplantation

Indexed keywords

ARTICLE; AUTOIMMUNITY; CLINICAL TRIAL; DEVICE; GENETIC ENGINEERING; GRAFT SURVIVAL; HUMAN; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LANGERHANS CELL; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RECURRENT DISEASE; SURGICAL TECHNIQUE;

EID: 0033736567     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004230000118     Document Type: Article

References (35)

1. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986
2. Sollinger HW, Odorico JS, Knechtle SJ, D'Alessandro AM. Kalayoglu M, Pirsch JD (1998) Experience with 500 simultaneous pancreas-kidney transplants. Ann Surg 228:284-296
3. Manske CL (1999) Risks and benefits of kidney and pancreas transplantation for diabetic patients. Diabetes Care 22[suppl2]:B114-B120
4. Federlin K, Pozza G (1999) Indications for clinical islet transplantation today and in the foreseeable future - the diabetologist's point of view. J Mol Med 77:148-152
5. Hering BJ, Ricordi C (1999) Results, research priorities, and reasons for optimism: islet transplantation for patients with type 1 diabetes. Graft 2:12-27
6. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW (1988) Automated method for isolation of human pancreatic islets. Diabetes 37:413-420
7. Ricordi C, Tzakis AG, Carroll PB, Zeng Y, Rilo HLR, Alejandro R, Shapiro R, Fung JJ, Demetris AJ, Mintz DH, Starzl TE (1992) Human islet isolation and allotransplantation in 22 consecutive cases. Transplantation 53:407-414
8. Linetsky E, Bottino R, Lehmann R, Alejandro R, Inverardi L, Ricordi C (1997) Improved human islet isolation using a new enzyme blend, liberase. Diabetes 46:1120-1123
9. Ricordi C (1996) Human islet cell transplantation: new perspectives for an old challenge. Diabetes Rev 4:356-369
10. Oberholzer J, Triponez F, Lou J, Morel P (1999) Clinical islet transplantation: a review. Ann N Y Acad Sei 875:189-199
11. International Islet Transplant Registry (1999) Newsletter no. 8
12. Meyer C, Hering BJ, Grossmann R, Brandhorst H, Brandhorst D, Gerich J, Federlin K, Bretzel RG (1998) Improved glucose counterregulation and autonomie symptoms after intraportal islet transplants alone in patients with long-standing type I diabetes mellitus. Transplantation 66:233-240
13. Bretzel RG, Brandhorst D, Brandhorst H, Echard M, Ernst W. Friemann S. Rau W, Weimar B. Rauber K, Hering BJ, Brendel MD (1999) Improved survival of intraportal pancreatic islet cell allografts in patients with type-1 diabetes mellitus by refined peritransplant management. J Mol Med 77:140-143
14. + T lymphocytes in primary nonfunction and classical rejection of islet allografts. J Exp Med 172: 291-302
15. Menger MD, Vajkoczy P, Leiderer R, Jager S, Messmer K (1992) Influence of experimental hyperglycemia on microvascular blood perfusion of pancreatic islet isografts. J Clin Invest 90:1361-1369
16. Shapiro AM, Gallant H, Hao E, Wong J, Rajotte R, Yatscoff R, Kneteman N (1997) Portal vein immunosuppressant levels and islet graft toxicity. Transplant Proc 30:641
17. Halloran PF, Homik J, Goes N, Lui SL, Urmson J, Ramassar V, Cockfield SM (1997) The "injury response": a concept linking nonspecific injury, acute rejection, and long-term transplant outcomes. Transplant Proc 29:79-81
18. Sutherland DER, Goetz PC, Sibley RK (1989) Recurrence of disease in pancreas transplants. Diabetes 38:85-87
19. Jaeger C, Brendel M, Hering BJ. Eckhard M, Bretzel RG (1997) Progressive islet graft failure occurs significantly earlier in autoantibodypositive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts. Diabetes 46:1907-1910
20. Berney T, Ricordi C (1999) Islet isolation. Cell Transplant 8:461-464
21. Kaufman DB, Gores PF, Field MJ, Farney AC, Gruber SA, Stephanian E, Sutherland DER (1994) Effect of 15deoxyspergualin on immediate function and long-term survival of transplanted islets in murine recipients of a marginal islet mass. Diabetes 43:778-783
22. Bottino R, FernandeJ. LA. Ricordi C. Lehmann R, Tsan MF, Oliver R, Inverardi L (1998) Transplantation of allogeneic islets of Langerhans in the rat liver: effects of macrophage depletion graft survival and microenvironment activation. Diabetes 47:316-323
23. Rabinovitch A, Suarez-Pinzon W, Strynadka K, Ju Q, Edelstein D, Brownlee M, Korbutt GS, Rajotte RV ( 1999) Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes 48:1223-1229
24. Kahan BD. Rapamycin (1998) Personal algorithms for use based on 250 treated renal allograft recipients. Transplant Proc 30:2185-2188
25. Hricik DE (1998) Withdrawal of immunosuppression: implications for composite tissue allograft transplantation. Transplant Proc 30:2721-2723
26. Ricordi C, Karatzas T, Nery J, Webb M, Selvaggi G, Fernandez L, Khan FA, Ruiz P, Schiff E, Oison L, Fernandez H, Bean J, Esquenazi V, Miller J, Tzakis AG (1997) High-dose donor bone marrow infusions to enhance allograft survival: the effect of timing. Transplantation 63:7-11
27. Ricordi C, Murase N, Rastellini C, Bahboo R, Demetris AJ, Starzl TE (1996) Indefinite survival of rat islet allografts following infusion of donor bone marrow without cytoablation. Cell Transplant 5:53-55
28. Basadonna GP, Auersvald L, Khuong CQ, Zheng XX, Kashio N, Zekzer D, Minozzo M, Qian H, Visser L, Diepstra A, Lazarovits AI, Poppema S, Strom TB, Rothstein DM (1998) Antibody mediated targeting of CD45 isoforms: A novel immunotherapeutic strategy. Proc Natl Acad Sei USA 95:3821-3826
29. Gainer AL, Korbutt GS, Rajotte RV, Warnock GL, Elliott JF (1997) Expression of CTLA4-Ig by biolistically transfected mouse islets promotes islet allograft survival. Transplantation 63:1017-1021
30. Kenyon NS, Chatzipetrou M, Masetti M, Ranuncoli A, Oliveira M, Wagner JL. Kirk AD, Harlan DM, Burkly LC, Ricordi C (1999) Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD 154. Proc Natl Acad Sei USA 96:8132-8137
31. Balasa B, Krahl T, Patstone G, Lee J, Tisch R, McDevitt HO, Sarvetnick N (1997) CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. J Immunol 159:4620-44627
32. Berney T, Ricordi C (1999) Immunoisolation of cells and tissues for transplantation. Cell Transplant 8:577-579
33. Soon-Shiong P, Heintz RE, Merideth N, Yao QX, Zheng T, Murphy M, Moloney MK, Schmehl M, Harris M, Mendez R, Mendez R, Sandford PA (1994) Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 343:950-951
34. Groth CG, Korsgren O, Tibell A, Tollemar J, Möller E, Bounder J, Östman J, Reinholt FP, Hellerström C, Andersson A (1994) Transplantation of porcine fetal pancreas to diabetic patients. Lancet 344:1402-1404
35. Heneine W, Tibell A, Switzer WM, Sandstrom P, Vazquez Rosales G, Mathews A, Korsgren O, Chapman LE, Folks TM, Groth CG (1998) No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet 352:695-699